<h4>Background</h4>Laser photocoagulation and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections constitute the current standard treatment for retinopathy of prematurity (ROP). Here, VEGFA is linked to retinopathy of prematurity.